Analysis of the key themes driving M&A activity reveals that digitalization accounted for 15 medical devices deals announced in Q2 2024, worth a total value of $320.1m. The $239m acquisition of InVitae by LABCORP was the industry’s largest disclosed deal. GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in Q2 2024 report helps understand the pivotal themes steering M&A activity in the industry. Buy the report here.
In value terms, digitalization-related deal activity increased by 21240% in Q2 2024 compared with the previous quarter’s total of $1.5m and rose by 11% as compared to Q2 2023. Related deal volume increased by 7% in Q2 2024 versus the previous quarter and was 114% higher than in Q2 2023.
The top-ranked financial advisors supporting these M&A deals in H1 2024 were Houlihan Lokey; Moelis & Co; Oaklins Germany with 1, 1, 1 deals respectively.
The top-ranked legal advisors supporting these M&A deals in H1 2024 were Kirkland & Ellis; Bose McKinney & Evans; Dentons UK and Middle East with 2, 1, 1 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In Q2 2024 – Thematic Intelligence, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.